Dear John,

The November 2025 issue of Health Affairs features articles on a variety of topics, including different aspects of Medicaid enrollment in the wake of the unwinding of COVID-19-era protections, employer sponsored health insurance, and issues surrounding the treatment of substance use disorders.

Health Affairs This Week: CMS Drug Price Negotiation Guidance Updates with Rachel Sachs

A Health Podyssey: Protecting Public Health in a Politicized Era w/ Michael Osterholm

Health Affairs, with support from the Robert Wood Johnson Foundation, released two new companion health policy briefs on exclusionary immigration policy and health.

Population Health Costs Of Exclusionary And Criminalizing Immigration Policies

Nolan Kline et al.

Mitigating The Health Impacts Of Exclusionary Immigration Policies: An Evidence Review

Nicole L. Novak et al.

District Court: Restrictions On Mifepristone Illegal But Will Remain In Effect Pending FDA Reconsideration

Katie Keith

part of our Health Policy At A Crossroads series

A 2025 Update On MIPS Value Pathways: Gradual Progress And Ongoing Challenges

Anushka Dasgupta et al.

Rapid Learning For Accountable Care Adoption

Valerie Lehman et al.

part of our Accountable Care For Population Health series

What’s In a Name? Challenges Facing Community Health Centers After HR 1

Sara Rosenbaum et al.

part of our Health Policy At A Crossroads series

I Watched Science Change The World. Here’s What Could Stop It.

Mark L. Rohrbaugh

More from Forefront

• Reforming Average Sales Price-Based Reimbursement For Infused Biosimilars
• Pediatric Gender Affirming Care And The Future Of Medical Advocacy
• Government Shutdown Could Worsen Environmental Safety And Public Health In Hard-Hit Communities
• Reviving Israeli-Palestinian Medical Collaboration For A Post-War Future
• MAHA’s Low-Hanging Fruit: Enabling Health Systems To Deploy Food As Medicine
• The Real Fraud, Waste, And Abuse: Medicare And Medicaid Privatization
• Congress Must Continue To Fund HIV Prevention And Treatment